Small Molecule Drug Discovery Market Size, Growth, Demands Outlook and Forecasts to 2032

According to the research report, the global smallmolecule drug discovery market size is expected to touch USD 163.76 Billion by 2032, from USD 75.96 Billion in 2022, growing with a significant CAGR of 7.97% from 2022 to 2032. 

The small molecule drug discovery market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global small molecule drug discovery market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global small molecule drug discovery market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global small molecule drug discovery market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/2512

 Report Scope of the Small Molecule Drug Discovery

Report Coverage	Details
Market Size in 2023	USD 82.03 Billion
Market Size by 2032	USD 163.76 Billion
Growth Rate from 2023 to 2032	CAGR of 7.97%
Base Year	2022
Forecast Period	2023 to 2032
Segments Covered	By Drug Type, By Technology, and By End-User
Regions Covered	North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

This study covers a detailed segmentation of the global small molecule drug discovery market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global small molecule drug discovery market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

• Pfizer Inc.
• GlaxoSmithKline PLC
• Merck & Co. Inc.
• Agilent Technologies Inc.
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd
• Bayer AG
• Abbott Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Shimadzu Corp

Market Segmentation

 By Drug Type

• Small Molecule Drugs
• Biologic Drugs

By Technology

• High Throughput Screening
• Pharmacogenomics
• Combinatorial Chemistry
• Nanotechnology
• Others

By End-user

• Pharmaceutical Companies
• Contract Research Organizations
• Others

By Regions

• North America
• Europe
• Asia-Pacific
• South America
• The Middle East and Africa

Research Methodology

The research methodology adopted by analysts for compiling the global small molecule drug discovery market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global small molecule drug discovery market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Small Molecule Drug Discovery Market 

5.1. COVID-19 Landscape: Small Molecule Drug Discovery Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Small Molecule Drug Discovery Market, By Drug Type

8.1. Small Molecule Drug Discovery Market, by Drug Type, 2022-2030

8.1.1 Small Molecule Drugs

8.1.1.1. Market Revenue and Forecast (2022-2032)

8.1.2. Biologic Drugs

8.1.2.1. Market Revenue and Forecast (2022-2032)

Chapter 9. Global Small Molecule Drug Discovery Market, By Technology

9.1. Small Molecule Drug Discovery Market, by Technology, 2022-2030

9.1.1. High Throughput Screening

9.1.1.1. Market Revenue and Forecast (2022-2032)

9.1.2. Pharmacogenomics

9.1.2.1. Market Revenue and Forecast (2022-2032)

9.1.3. Combinatorial Chemistry

9.1.3.1. Market Revenue and Forecast (2022-2032)

9.1.4. Nanotechnology

9.1.4.1. Market Revenue and Forecast (2022-2032)

9.1.5. Others

9.1.5.1. Market Revenue and Forecast (2022-2032)

Chapter 10. Global Small Molecule Drug Discovery Market, By End-User 

10.1. Small Molecule Drug Discovery Market, by End-User, 2022-2030

10.1.1. Pharmaceutical Companies

10.1.1.1. Market Revenue and Forecast (2022-2032)

10.1.2. Contract Research Organizations

10.1.2.1. Market Revenue and Forecast (2022-2032)

10.1.3. Others

10.1.3.1. Market Revenue and Forecast (2022-2032)

Chapter 11. Global Small Molecule Drug Discovery Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.1.2. Market Revenue and Forecast, by Technology (2022-2032)

11.1.3. Market Revenue and Forecast, by End-User (2022-2032)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.1.4.2. Market Revenue and Forecast, by Technology (2022-2032)

11.1.4.3. Market Revenue and Forecast, by End-User (2022-2032)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.1.5.2. Market Revenue and Forecast, by Technology (2022-2032)

11.1.5.3. Market Revenue and Forecast, by End-User (2022-2032)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.2.2. Market Revenue and Forecast, by Technology (2022-2032)

11.2.3. Market Revenue and Forecast, by End-User (2022-2032)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.2.4.2. Market Revenue and Forecast, by Technology (2022-2032)

11.2.4.3. Market Revenue and Forecast, by End-User (2022-2032)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.2.5.2. Market Revenue and Forecast, by Technology (2022-2032)

11.2.5.3. Market Revenue and Forecast, by End-User (2022-2032)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.2.6.2. Market Revenue and Forecast, by Technology (2022-2032)

11.2.6.3. Market Revenue and Forecast, by End-User (2022-2032)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.2.7.2. Market Revenue and Forecast, by Technology (2022-2032)

11.2.7.3. Market Revenue and Forecast, by End-User (2022-2032)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.3.2. Market Revenue and Forecast, by Technology (2022-2032)

11.3.3. Market Revenue and Forecast, by End-User (2022-2032)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.3.4.2. Market Revenue and Forecast, by Technology (2022-2032)

11.3.4.3. Market Revenue and Forecast, by End-User (2022-2032)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.3.5.2. Market Revenue and Forecast, by Technology (2022-2032)

11.3.5.3. Market Revenue and Forecast, by End-User (2022-2032)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.3.6.2. Market Revenue and Forecast, by Technology (2022-2032)

11.3.6.3. Market Revenue and Forecast, by End-User (2022-2032)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.3.7.2. Market Revenue and Forecast, by Technology (2022-2032)

11.3.7.3. Market Revenue and Forecast, by End-User (2022-2032)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.4.2. Market Revenue and Forecast, by Technology (2022-2032)

11.4.3. Market Revenue and Forecast, by End-User (2022-2032)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.4.4.2. Market Revenue and Forecast, by Technology (2022-2032)

11.4.4.3. Market Revenue and Forecast, by End-User (2022-2032)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.4.5.2. Market Revenue and Forecast, by Technology (2022-2032)

11.4.5.3. Market Revenue and Forecast, by End-User (2022-2032)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.4.6.2. Market Revenue and Forecast, by Technology (2022-2032)

11.4.6.3. Market Revenue and Forecast, by End-User (2022-2032)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.4.7.2. Market Revenue and Forecast, by Technology (2022-2032)

11.4.7.3. Market Revenue and Forecast, by End-User (2022-2032)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.5.2. Market Revenue and Forecast, by Technology (2022-2032)

11.5.3. Market Revenue and Forecast, by End-User (2022-2032)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.5.4.2. Market Revenue and Forecast, by Technology (2022-2032)

11.5.4.3. Market Revenue and Forecast, by End-User (2022-2032)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Drug Type (2022-2032)

11.5.5.2. Market Revenue and Forecast, by Technology (2022-2032)

11.5.5.3. Market Revenue and Forecast, by End-User (2022-2032)

Chapter 12. Company Profiles

12.1. Pfizer Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. GlaxoSmithKline PLC

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Merck & Co. Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Agilent Technologies Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Eli Lilly and Company

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. F. Hoffmann-La Roche Ltd

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Bayer AG  

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Abbott Laboratories Inc.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Thermo Fisher Scientific Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Shimadzu Corp

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com